Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christoforos Haritos"'
Autor:
Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-12 (2017)
Abstract Background Tumor immune cell infiltrates are essential in hindering cancer progression and may complement the TNM classification. CD8+ and CD163+ cells have prognostic impact in breast cancer but their spatial heterogeneity has not been exte
Externí odkaz:
https://doaj.org/article/b1fc8a555ad9495090e0555162dc20f2
Autor:
Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-2 (2017)
Externí odkaz:
https://doaj.org/article/012030cb20214e53a1b39c32d138484a
Autor:
Graham Pawelec, Constantin N. Baxevanis, Niki Arnogiannaki, Christoforos Vaxevanis, Alexandros Ardavanis, Sonia A. Perez, Nectaria N. Sotiriadou, Nicole Janssen, Eleftheria A. Anastasopoulou, Michael Sofopoulos, Sotirios P Fortis, Christoforos Haritos
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-12 (2017)
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-12 (2017)
Background Tumor immune cell infiltrates are essential in hindering cancer progression and may complement the TNM classification. CD8+ and CD163+ cells have prognostic impact in breast cancer but their spatial heterogeneity has not been extensively e
Autor:
Michael Sofopoulos, Graham Pawelec, Nicole Janssen, Christopher Shipp, Catherine Stavropoulos-Giokas, Christoforos Haritos, Lisa Speigl, Sotirios P Fortis, Nectaria N. Sotiriadou, Niki Arnogiannaki, Sonia A. Perez, Amalia Dinou, Constantin N. Baxevanis
Publikováno v:
Breast cancer research and treatment. 161(1)
Breast cancer is a leading cause of cancer deaths in women, but despite steady improvements in therapies, treatment is still suboptimal. Immunotherapy holds promise as a more effective therapy for breast cancer; supporting this, our prior study showe
Autor:
Constantin N. Baxevanis, Christopher Shipp, Graham Pawelec, Jithendra Kini Bailur, Nicole Janssen, Christoforos Haritos, Sonia A. Perez, Lisa Speigl, Sotirios P Fortis
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts It is becoming increasingly clear that the immune profile of breast cancer patients is informative for patient prognosis. Specifically, immune cells with suppressor or effector function have been shown to be valuable in the predicti
Autor:
Sotirios P Fortis, Nikolaos Anastasopoulos, Constantin N. Baxevanis, Louisa G. Mahaira, Sonia A. Perez, Nectaria N. Sotiriadou, Michael Sofopoulos, Christopher Shipp, John F Voutsas, Niki Arnogiannaki, Christoforos Haritos, Graham Pawelec
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Recent studies linking immune signatures in cancer with prognosis have provided unequivocal proof of the essential role of the immune system in tumor pathophysiology. They have also initiated a quest for immune biomarkers that could